(LifeSiteNews) — The European Union’s agency for the evaluation of medication is officially recommending that European babies as young as six months old get jabbed with the experimental mRNA COVID-19 shots.
The European Medicines Agency (EMA), which is charged with evaluating medicinal products for the 27-country bloc, made the recommendation in a press release issued Wednesday.
In the statement, the EMA recommended offering the Pfizer or Moderna mRNA COVID shots to babies just six months old and up.
‼️ EMA has recommended authorising the use of mRNA #COVID19vaccines in younger age groups:
➡️From 6 months to 4 years for Comirnaty
➡️From 6 months to 5 years for Spikevax
— EU Medicines Agency (@EMA_News) October 19, 2022
“EMA’s human medicines committee (CHMP) has recommended extending the use of Comirnaty and Spikevax targeting the original strain of SARS-CoV-2,” the press release reads, referencing the brand names of the jabs produced by Pfizer-BioNTech and Moderna, respectively.
“The Committee recommended including the use in children aged 6 months to 4 years for Comirnaty and use in children aged 6 months to 5 years for Spikevax,” the statement adds, noting that both the Pfizer and Moderna shots “are already approved in both adults and children aged from 5 and 6 years, respectively.”
The news comes as public health officials and politicians gin up anxiety about a potential winter surge of COVID-19, despite the fact that most people have either gotten the experimental jabs against the virus or have developed natural immunity through infection.
The push also comes in spite of evidence that children’s risk from COVID had been exaggerated. Available data going back to the beginning of the pandemic has long suggested that children face a very low risk from the virus.
In March, Florida Surgeon General Joseph Ladapo issued formal guidance advising against vaccination of children ages 5-17.
“Based on currently available data, the risks of administering COVID-19 vaccination among healthy children may outweigh the benefits,” Ladapo said in a press release.
The state’s official guidance further explained that “[i]n general, healthy children with no significant underlying health conditions under 16 years old are at little to no risk of severe illness complications from COVID-19.” In addition, the guidance flagged potential risks from the jabs, including the “higher than anticipated severe adverse events” recorded in clinical trials and the reported “[r]isk of myocarditis due to the COVID-19 vaccine.”
The American Pediatric Association reported in June that just 0.00%-0.02% of child COVID cases in the United States had resulted in death. The U.S. Centers for Disease Control and Prevention (CDC) admitted in March it had overcounted the number of pediatric COVID deaths by 25%.
Despite the low risk posed to children by the virus, however, the EU has actually lagged behind the U.S. in approving the jabs for babies.
The U.S. Food and Drug Administration authorized the Pfizer and Moderna drugs for infants six months and up in June.
That same month, Florida’s Department of Health announced it would not participate in the rollout of COVID drugs for kids ages six months to five years old, saying the federal government’s “convoluted” vaccine policies did not align with Florida’s priorities.
Florida has stood alone in resisting the prevailing narrative on COVID jabs for children. Despite the Sunshine State’s decision to stand apart, the federal government has continued to push for universal immunization.
On Wednesday, the 15-member panel of the CDC’s Advisory Committee on Immunization Practices voted unanimously to add the Moderna and Pfizer COVID shots to the recommended immunization schedules for school children.
The CDC is anticipated to adopt the COVID jabs into the recommended vaccination schedule when it conducts its official vote Thursday.